Coiante Scott M
Insider CIK 1608536 · LXRX SVP, Chief Financial Officer · AGRX Chief Financial Officer · APRE SVP, Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 160,237 | — | $0 | 320,473 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2026-02-28 | 2026-03-03 | 54,881 | $1.47 | $80.7K | 105,356 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 160,237 | — | $0 | 160,237 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 272,680 | — | $0 | 272,680 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 409,020 | — | $0 | 409,020 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 721,070 | — | $0 | 721,070 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 480,710 | — | $0 | 480,710 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-01-02 | 2025-01-02 | 230,000 | — | $0 | 230,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | D To issuer | 2024-08-26 | 2024-08-26 | 15,000 | $1.52 | $22.8K | 5,080 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | D To issuer | 2024-08-26 | 2024-08-26 | 5,080 | $1.52 | $7.7K | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award | 2023-10-03 | 2023-10-04 | 20,000 | — | $0 | 20,080 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-07-28 | 2022-08-01 | 89,200 | — | $0 | 89,200 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-07-28 | 2022-08-01 | 60,800 | — | $0 | 145,065 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2022-06-03 | 2022-06-07 | 35,284 | $0.81 | $28.6K | 84,265 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2022-03-10 | 2022-03-14 | 185,900 | — | $0 | 185,900 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2022-03-10 | 2022-03-14 | 42,900 | — | $0 | 119,549 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2022-02-25 | 2022-03-01 | 14,817 | $1.74 | $25.8K | 76,649 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | F Tax w/h | 2021-08-25 | 2021-08-27 | 7,534 | $3.98 | $30.0K | 91,466 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2021-02-25 | 2021-03-01 | 143,000 | — | $0 | 143,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-02-25 | 2021-03-01 | 63,500 | — | $0 | 99,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award | 2021-02-25 | 2021-03-01 | 33,000 | — | $0 | 35,500 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2020-03-24 | 2020-03-26 | 55,000 | — | $0 | 55,000 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | A Award deriv | 2019-10-07 | 2019-10-07 | 150,824 | — | $0 | 150,824 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2019-10-07 | 2019-10-07 | 2,500 | $15.00 | $37.5K | 2,500 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2019-01-29 | 2019-01-31 | 38,500 | — | $0 | 38,500 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2019-01-29 | 2019-01-31 | 172,600 | — | $0 | 172,600 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise deriv | 2019-01-25 | 2019-01-28 | 17,500 | — | $0 | 0 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise | 2019-01-25 | 2019-01-28 | 17,500 | — | $0 | 48,256 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise deriv | 2019-01-24 | 2019-01-28 | 16,070 | — | $0 | 17,500 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise | 2019-01-24 | 2019-01-28 | 16,070 | — | $0 | 30,756 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2018-06-20 | 2018-06-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise deriv | 2018-01-25 | 2018-01-26 | 17,500 | — | $0 | 33,570 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | M Exercise | 2018-01-25 | 2018-01-26 | 17,500 | — | $0 | 21,439 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | F Tax w/h | 2018-01-25 | 2018-01-26 | 6,753 | $3.32 | $22.4K | 14,686 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2018-01-24 | 2018-01-26 | 16,070 | — | $0 | 51,070 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2018-01-24 | 2018-01-26 | 107,000 | — | $0 | 107,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2017-01-25 | 2017-01-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2017-01-25 | 2017-01-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2016-02-08 | 2016-02-10 | 95,000 | — | $0 | 95,000 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2015-02-19 | 2015-02-23 | 37,500 | — | $0 | 37,500 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2015-02-19 | 2015-02-23 | 37,500 | — | $0 | 37,500 | SEC↗ |
| AGRX AGILE THERAPEUTICS INC | A Award deriv | 2014-06-24 | 2014-06-26 | 118,000 | — | $0 | 118,000 | SEC↗ |